1Renal transplantation in congenital and metabolic diseases.A report from the ASC/NIH renal transplant registry.JAMA,1975,232:148-153.
2Stone JH.End-stage renal disease in lupus:disease activity,dialysis,and the outcome of transplantation.Lupus,1998,7:654-659.
3Amore A,Coppo R.Immunological basis of inflammation in dialysis.Nephrol Dial Transplant,2002,17 Suppl 8:16-24.
4Stone JH,Amend WJ,Criswell LA.Outcome of renal transplantation in systemic lupus erythematosus.Semin Arthritis Rheum,1997,27:17-26.
5Meier-Kriesche HU,Port FK,Ojo AO,et al.Effect of waiting time on renal transplant outcome.Kidney Int,2000,58:1311-1317.
6Huang JW,Hung KY,Yen CJ,et al.Systemic lupus erythematosus and peritoneal dialysis:outcomes and infectious complications.Perit Dial Int,2001,21:143-147.
7Servilla KS,Tzamaloukas AH.Exacerbation of extrarenal systemic lupus erythematosus following peritonitis in peritoneal dialysis.Perit Dial Int,2003,23:96-97.
8McIntyre JA,Wagenknecht DR.Antiphospholipid antibodies.Risk assessments for solid organ,bone marrow,and tissue transplantation.Rheum Dis Clin North Am,2001,27:611-631.
9Lochhead KM,Pirsch JD,D'Alessandro AM,et al.Risk factors for renal allograft loss in patients with systemic lupus erythematosus.Kidney Int,1996,49:512-517.
10Stone JH,Amend WJ,Criswell LA.Antiphospholipid antibody syndrome in renal transplantation:occurrence of clinical events in 96 consecutive patients with systemic lupus erythematosus.Am J Kidney Dis,1999,34:1040-1047.
